JDRF celebrates Health Canada’s new licence for technology that will improve the lives of people with type 1 diabetes
10 oct. 2018 14h56 HE
|
Juvenile Diabetes Research Foundation Canada
Approval of Canada’s first Hybrid Closed-Loop System will help Canadians with type 1 diabetes keep their blood sugar levels in an optimal range for a greater amount of time TORONTO, Oct. 10, 2018 ...
Sernova Announces $2,000,000 First Closing of Private Placement
16 juil. 2018 06h00 HE
|
Sernova Corp
Due to Oversubscription, Offering Increased to $2,700,000 THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.LONDON, Ontario,...
Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes
05 juil. 2018 06h00 HE
|
Sernova Corp
LONDON, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces that patient screening and recruitment has begun in its...
InSphero Partners with ALPCO to Advance Diabetes Research
11 juin 2018 09h00 HE
|
InSphero AG
Schlieren, Switzerland, June 11, 2018 (GLOBE NEWSWIRE) -- InSphero AG, the leading provider of 3D cell-based platforms for preclinical drug safety and efficacy testing, today announced that it is...
Internal CRA documents show intent to deny the disability tax credit to Canadians with type 1 diabetes
04 déc. 2017 10h00 HE
|
Juvenile Diabetes Research Foundation Canada; Diabetes Canada / Diabete Canada
OTTAWA, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Diabetes Canada and JDRF join today in expressing disappointment after receiving a copy of an internal Canada Revenue Agency (CRA) email demonstrating that...
Media Advisory: Canada’s leading diabetes organizations to provide an update on efforts to reverse changes to the Disability Tax Credit
01 déc. 2017 17h57 HE
|
Juvenile Diabetes Research Foundation Canada
OTTAWA, Dec. 01, 2017 (GLOBE NEWSWIRE) -- WHAT: Canada’s leading diabetes organizations to host a NEWS CONFERENCE to provide new information about their efforts to reverse changes in...
JDRF-Funded Study on Continuous Glucose Monitoring (CGM) in Pregnant Women with Type 1 Diabetes Shows Improved Outcomes for Their Newborns
31 oct. 2017 14h36 HE
|
Juvenile Diabetes Research Foundation Canada
TORONTO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Babies born to women with type 1 diabetes (T1D) may soon be at a reduced risk of complications after a JDRF-funded study revealed that observing blood...
FRDJ et Lilly Canada financent à l'UCB des recherches susceptibles de permettre aux personnes ayant le diabète de type 1 de produire leur propre insuline
07 févr. 2017 11h39 HE
|
JDRF/FRDJ
VANCOUVER, BC--(Marketwired - 7 février 2017) - FRDJ et Lilly Canada ont attribué une bourse de recherche postdoctorale de 60 000 $CA à une chercheuse prometteuse, la Dre Cara Ellis, boursière...
JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin
07 févr. 2017 11h38 HE
|
JDRF/FRDJ
VANCOUVER, BC--(Marketwired - February 07, 2017) - JDRF and Lilly Canada have awarded a post-doctoral fellowship grant of CAN$60,000 to promising researcher Dr. Cara Ellis, a post-doctoral fellow...
Xeris Pharmaceuticals, Inc. to Present G-Pen Human Factors Study Results at 2016 ATTD Meeting
04 févr. 2016 10h22 HE
|
Xeris Pharmaceuticals, Inc.
Austin, TX, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”) will present data from a human factors study with its G-PenTM glucagon auto-injector during the 9th International...